Ching Hsu

Efficacy and Safety of Mirogabalin (DS-5565) for the Treatment of Diabetic Peripheral Neuropathic Pain: A Randomized, Double-Blind, Placebo- and Active Comparator–Controlled, Adaptive Proof-of-Concept Phase 2 Study

Aaron Vinik, Julio Rosenstock, Uma Sharma et al. · Diabetes Care · 2014 · 97 citations

Medicine, Pharmacology, Pharmacotherapy +17

A randomized, placebo‐controlled, phase 1/2 study of tivantinib (ARQ 197) in combination with irinotecan and cetuximab in patients with metastatic colorectal cancer with wild‐type <i>KRAS</i> who have received first‐line systemic therapy

Cathy Eng, Alberto Bessudo, Lowell L. Hart et al. · International Journal of Cancer · 2016 · 69 citations · Full text

Medicine, Oncology, Pharmacology +17

Double-blind, randomized, parallel, placebo-controlled study of ibuprofen effects on thromboxane B2 concentrations in aspirin-tereated healthy adult volunteers

Byron Cryer, Roger G. Berlin, Stephen A. Cooper et al. · Clinical Therapeutics · 2005 · 41 citations

Medicine, Pharmacology, Pharmacotherapy +9

Efficacy of Mirogabalin (DS-5565) on Patient-Reported Pain and Sleep Interference in Patients with Diabetic Neuropathic Pain: Secondary Outcomes of a Phase II Proof-of-Concept Study

Domenico Merante, Julio Rosenstock, Uma Sharma et al. · Pain Medicine · 2017 · 36 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Tolerability, pharmacokinetics, and pharmacodynamics of mirogabalin in healthy subjects: Results from phase 1 studies

Karen Brown, Jeanne Mendell, Shoichi Ohwada et al. · Pharmacology Research & Perspectives · 2018 · 31 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +11